0 items
Your cart is empty.
Research-grade peptide compounds supplied for in vitro investigation of anabolic signaling pathways, myogenic differentiation, and receptor pharmacology models.
Research-grade recombinant protein hormone formulated in 10IU quantity for protein structure characterization and recombinant hormone analytical studies in controlled laboratory environments.
Research-grade peptide intended for controlled laboratory studies. IGF-1 DES (1mg) is a precision-synthesized research peptide produced with verified batch purity and documented analytical validation. Each 1mg vial is prepared for...
Research-grade synthetic modified insulin-like growth factor peptide formulated in 1mg quantity for extended peptide analog studies and modified growth factor characterization research in controlled laboratory environments.
Ipamorelin 5mg from Novera is a selective growth hormone releasing peptide (GHRP) formulated exclusively for preclinical and laboratory research applications. This pentapeptide stimulates growth hormone (GH) secretion with minimal off-target...
Research-grade selective synthetic pentapeptide formulated for experimental peptide interaction research in controlled laboratory settings.
Research-grade peptide intended for controlled laboratory studies.
Research-grade synthetic growth hormone-releasing hormone analog formulated in 5mg quantity for GHRH peptide studies and pituitary hormone research in controlled laboratory environments.
A synthetic analog of growth hormone-releasing hormone studied for pituitary GHRH receptor binding kinetics, somatotroph cell signaling pathway dynamics, and downstream IGF-1 axis marker activity in extended preclinical research protocols.
Research-grade synthetic peptide analog formulated for regulatory peptide signaling investigations and peptide analog structure characterization in controlled laboratory environments.
Research-grade synthetic peptide supplied in an 8mg format for controlled in vitro investigation of growth hormone–releasing hormone receptor (GHRH-R) interaction and intracellular signaling pathway models.
A synthetic 44-amino acid analog of growth hormone-releasing hormone studied for pituitary receptor binding kinetics, GHRH pathway signaling dynamics, and downstream somatotropic axis marker activity in controlled preclinical models.
We work with leading pharmaceutical brands specializing in Muscle Growth & Performance Peptides medications, selected for their clinical reliability, regulatory compliance, and consistent treatment outcomes.
Primary experimental domains include:
All research contexts are mechanistic and cell-based.
Store lyophilized materials at -20°C in desiccated conditions.
Reconstitute under sterile laboratory conditions appropriate to the assay system.
Avoid repeated freeze-thaw cycles.
Endotoxin-controlled handling is recommended for primary myoblast cultures.
Documentation includes:
Compounds are designated strictly as research-use biochemicals.
Includes:
